PodcastThe Directors The Directors: Ben Ho Park and Suresh Ramalingam discuss tough times, uncertainty, and resilience“If you’re going to be an oncologist, we look at the glass 5% full, not 95% empty.” September 12, 2025Vol.51 No.33By Claire Marie Porter, Jacquelyn Cobb and Paul Goldberg
Podcast On Capitol Hill, NIH gets congressional support and RFK Jr. gets slammed September 10, 2025Vol.51 No.32
Capitol Hill House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99MHouse joins Senate in rejecting Trump’s proposed 40% NIH cuts September 05, 2025Vol.51 No.32By Jacquelyn Cobb and Paul Goldberg
Guest Editorial Curing cancer or curbing immigration: A question of national morality and priority September 05, 2025Vol.51 No.32By Paul W. Thurman
In Brief Julie Bauman named deputy chair of NRG Oncology’s NCORP research program, Ryan Burri named vice chair of Veteran Affairs research September 05, 2025Vol.51 No.32
Podcast In The Headlines: A good week for NIH, a bad week for Vinay Prasad August 06, 2025Vol.51 No.30
Podcast In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial. July 30, 2025Vol.51 No.29
Conversation with The Cancer Letter Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out July 25, 2025Vol.51 No.29By Sara Willa Ernst, Jacquelyn Cobb and Paul Goldberg
Cancer Policy FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts July 25, 2025Vol.51 No.29By Jacquelyn Cobb
